Sunwels Co.,Ltd. (TYO:9229)
Japan · Delayed Price · Currency is JPY 877.00
-8.00 (-0.90%)
Aug 13, 2025, 3:30 PM JST
Blueprint Medicines Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 26,465 | 26,496 | 20,107 | 13,236 | 8,174 | 5,404 | Upgrade | |
Revenue Growth (YoY) | 19.65% | 31.77% | 51.91% | 61.93% | 51.26% | 23.41% | Upgrade |
Cost of Revenue | 22,873 | 21,581 | 14,938 | 9,971 | 6,314 | 4,028 | Upgrade |
Gross Profit | 3,592 | 4,915 | 5,169 | 3,265 | 1,860 | 1,376 | Upgrade |
Selling, General & Admin | 3,439 | 3,274 | 2,567 | 2,038 | 1,420 | 1,054 | Upgrade |
Other Operating Expenses | 504 | 504 | 343 | 247 | 167 | - | Upgrade |
Operating Expenses | 3,965 | 3,800 | 2,931 | 2,311 | 1,615 | 1,054 | Upgrade |
Operating Income | -373 | 1,115 | 2,238 | 954 | 245 | 322 | Upgrade |
Interest Expense | -887 | -814 | -635 | -372 | -160 | -46 | Upgrade |
Interest & Investment Income | 3 | 3 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 140 | 84 | 81 | 77 | 17 | 40 | Upgrade |
EBT Excluding Unusual Items | -1,117 | 388 | 1,684 | 659 | 102 | 316 | Upgrade |
Asset Writedown | -2 | -3 | - | -6 | -2 | - | Upgrade |
Other Unusual Items | -701 | -701 | -17 | - | - | 15 | Upgrade |
Pretax Income | -1,820 | -316 | 1,667 | 653 | 100 | 331 | Upgrade |
Income Tax Expense | 350 | 609 | 888 | 350 | 90 | 90 | Upgrade |
Net Income to Company | - | -925 | 779 | 303 | 10 | 241 | Upgrade |
Net Income | -2,170 | -925 | 779 | 303 | 10 | 241 | Upgrade |
Net Income to Common | -2,170 | -925 | 779 | 303 | 10 | 241 | Upgrade |
Net Income Growth | - | - | 157.10% | 2930.00% | -95.85% | 62.84% | Upgrade |
Shares Outstanding (Basic) | 32 | 32 | 30 | 9 | 8 | 8 | Upgrade |
Shares Outstanding (Diluted) | 32 | 32 | 30 | 9 | 8 | 8 | Upgrade |
Shares Change (YoY) | 6.65% | 4.64% | 223.84% | 21.21% | - | - | Upgrade |
EPS (Basic) | -67.10 | -29.10 | 25.83 | 32.30 | 1.29 | 31.14 | Upgrade |
EPS (Diluted) | -67.10 | -29.10 | 25.64 | 32.30 | 1.29 | 31.14 | Upgrade |
EPS Growth | - | - | -20.61% | 2399.77% | -95.85% | 62.84% | Upgrade |
Free Cash Flow | - | -2,324 | -2,932 | -741 | -74 | - | Upgrade |
Free Cash Flow Per Share | - | -73.10 | -96.50 | -78.98 | -9.56 | - | Upgrade |
Gross Margin | 13.57% | 18.55% | 25.71% | 24.67% | 22.75% | 25.46% | Upgrade |
Operating Margin | -1.41% | 4.21% | 11.13% | 7.21% | 3.00% | 5.96% | Upgrade |
Profit Margin | -8.20% | -3.49% | 3.87% | 2.29% | 0.12% | 4.46% | Upgrade |
Free Cash Flow Margin | - | -8.77% | -14.58% | -5.60% | -0.91% | - | Upgrade |
EBITDA | 1,158 | 2,499 | 3,035 | 1,447 | 556 | - | Upgrade |
EBITDA Margin | 4.38% | 9.43% | 15.09% | 10.93% | 6.80% | - | Upgrade |
D&A For EBITDA | 1,531 | 1,384 | 797 | 493 | 311 | - | Upgrade |
EBIT | -373 | 1,115 | 2,238 | 954 | 245 | 322 | Upgrade |
EBIT Margin | -1.41% | 4.21% | 11.13% | 7.21% | 3.00% | 5.96% | Upgrade |
Effective Tax Rate | - | - | 53.27% | 53.60% | 90.00% | 27.19% | Upgrade |
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.